On Grindeks financial results in the three months of 2016

Category: News

On Grindeks financial results in the three months

On Grindeks financial results in the three months of 2016

Today, on 27 May, the JSC Grindeks submitted the non-audited consolidated financial statements for the first quarter of 2016 to Nasdaq Riga. Non-audited financial results...
27/05/2016
→
Annual Report and Corporate Social Responsibility Report 2016

Draft Resolutions of Annual General Meeting of Shareholders of JSC Grindeks to be held on 7 June 2016

Approved at the meeting of the Board of joint stock company Grindeks on 24 May 2016 and revised at the meeting of the Supervisory Council...
24/05/2016
→
mildronate

On Grindeks audited results in 2015

Today, on 29 April, the JSC Grindeks submitted the audited consolidated financial statements of 2015 to Nasdaq Riga. Audited financial results indicate that the Group’s...
29/04/2016
→
mildronate

Mildronate® is not a doping

JSC Grindeks, the manufacturer of Mildronate® (meldonium), has submitted an open letter to the World Anti-Doping Agency (WADA). According to the JSC Grindeks, WADA has...
18/04/2016
→
evidence-that-meldonium-enhances

Experts: There’s no evidence that meldonium enhances performance

There’s really no evidence that there’s any performance enhancement from meldonium, said Don Catlin, a long-time anti-doping expert and the scientific director of the Banned...
08/04/2016
→
maratons

Grindeks: Meldonium should not be included in the Prohibited list

Despite Grindeks submitted arguments, evidence and justifications, the World Anti-Doping Agency (WADA) included meldonium in the Prohibited list. In accordance with the results of the...
09/03/2016
→
On-Grindeks-results-in-2015

On Grindeks results in 2015

Today, on 26 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2015 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...
26/02/2016
→

The Financial Calendar of JSC Grindeks for the year of 2016

JSC Grindeks will publish its: non-audited financial statement for the 12-month period of 2015 on February 26, 2016; non-audited interim financial statement for the 3-month...
18/12/2015
→

On Grindeks financial results in the nine months of 2015

Today, on 27 November, the JSC Grindeks submitted the non-audited consolidated financial statements for the nine months of 2015 to “Nasdaq Riga”. Non-audited financial results...
27/11/2015
→
cropped

Grindeks and “Kalceks” participate in the international exhibition “CPhI Worldwide 2015”

From 13th to 15th of October, 2015, Grindeks and its subsidiary “Kalceks” participate in the leading pharmaceutical exhibition “CPhI Worldwide 2015” in Madrid, Spain. During...
13/10/2015
→

Company’s announcment

JSC Grindeks announces that due to technical issues JSC Grindeks announcements published in the Nasdaq news distribution service system (GlobeNewswire) on 09 January, 2015, 27...
10/10/2015
→
Grindeks-sanem-ISO-sertifikatus4

Grindeks receives the Energy management system certification LVS EN ISO 50001:2012 (ISO 50001:2011)

JSC Grindeks announces it has received a certificate approving the adequacy of its Energy management to the requirements of LVS EN ISO 50001:2012 standard. To...
09/10/2015
→
bebis

Grindeks supplies oxytocin injections to the World Health Organization

JSC Grindeks announced today it has concluded a long-term cooperation agreement with the World Health Organization (WHO) on the oxytocin supplies. In accordance with the...
24/09/2015
→

The Governor of Ulyanovsk Oblast Sergey Morozov visits Grindeks

Today, on 4 September the joint stock company Grind will be visited by the Governor of Ulyanovsk Oblast (Russia) Sergey Morozov and his delegation. During...
04/09/2015
→

On Grindeks financial results in the first six months of 2015

Today, on 28 August, the JSC Grindekssubmitted the non-audited consolidated financial statements for the first six months of 2015 to Nasdaq Riga. Non-audited financial results...
28/08/2015
→
1 … 7 8 9 10 11 … 17
magnifiercrossmenu